Company Profile
Immix Biopharma Stock Price, News & Analysis
- Ticker:
- IMMX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
10.06 USD (+5.45%)
Close
Last updated: August 6, 2026
596M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IMMX closed up 5.45% at $10.06. No new same-company headline was identified in the current news window.
Company overview
Business overview
Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Immix sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, platform validation, and the ability to build a differentiated cancer story.
Position Within the Biotechnology Landscape
Immix is a catalyst-sensitive biotech name whose stock depends on early clinical progress.
Future catalysts
Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path. The story remains early and data-dependent.
Recent news
- 01
- 02
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
Source: Immix Biopharma
- 03
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
Source: Immix Biopharma
- 04
- 05
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
Source: Immix Biopharma
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Immix Biopharma (IMMX)?
Immix Biopharma (IMMX) most recently closed at 10.06 USD, a +5.45% move versus the previous session.
What is the market cap of Immix Biopharma (IMMX)?
Immix Biopharma currently has a market capitalization of 596M USD on BioPharmSignal.
What does Immix Biopharma do?
Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.
On which exchange is IMMX stock listed?
Immix Biopharma (IMMX) is associated with NASDAQ, United States, Biopharma.
What is Immix?
Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path.
Which conditions is Immix Biopharma targeting with Immix?
Immix Biopharma is associated with oncology, immunology based on its company overview and current catalyst commentary.
How does Immix Biopharma describe recent progress with Immix?
Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path.
What is Biopharma?
Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs.